Your browser doesn't support javascript.
loading
Faecal immunochemical test-based colorectal cancer screening in Mexico: an initial experience.
Remes-Troche, José María; Hinojosa-Garza, Gabriela; Espinosa-Tamez, Priscilla; Meixueiro-Daza, Arturo; Grube-Pagola, Peter; Van Loon, Katherine; Potter, Michael B; Lajous, Martin.
Afiliação
  • Remes-Troche JM; Departamento de Gastroenterología, Instituto de Investigaciones Médico Biológicas, Universidad Veracruzana, Veracruz, México.
  • Hinojosa-Garza G; Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Mexico City, Mexico.
  • Espinosa-Tamez P; Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Mexico City, Mexico.
  • Meixueiro-Daza A; Departamento de Gastroenterología, Instituto de Investigaciones Médico Biológicas, Universidad Veracruzana, Veracruz, México.
  • Grube-Pagola P; Departamento de Anatomía Patológica, Hospital de Alta Especialidad, Centro Médico Nacional «Adolfo Ruiz Cortines¼, Instituto Mexicano del Seguro Social, Veracruz, México.
  • Van Loon K; UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA.
  • Potter MB; San Francisco Bay Area Collaborative Research Network, University of California San Francisco Clinical and Translational Science Institute, San Francisco, USA.
  • Lajous M; Departamento de Gastroenterología, Instituto de Investigaciones Médico Biológicas, Universidad Veracruzana, Veracruz, México.
Fam Pract ; 37(3): 321-324, 2020 07 23.
Article em En | MEDLINE | ID: mdl-31961429
ABSTRACT

BACKGROUND:

In middle-income countries, the burden of colorectal cancer (CRC) is increasing in parallel with resources for diagnosis and treatment. There is a potential benefit of CRC screening programs in Mexico.

OBJECTIVE:

Since there are no organized screening programs in the country, we explored the willingness of individuals to complete a faecal immunochemical testing (FIT) based CRC screening program and its potential benefit in Mexico.

METHODS:

We conducted a CRC screening program pilot in Veracruz, Mexico, during 2015-16 using FIT. Individuals with FIT results >100 ng of haemoglobin/ml buffer were referred for diagnostic colonoscopy.

RESULTS:

Of 473 FIT kits distributed to adults aged 50-75, 85.8% (406) were completed by participants and analysed in the laboratory. Of these, 5.9% (24/406) of test results showed >100 ng haemoglobin/ml. Twenty-one participants completed colonoscopy. The positive predictive value of FIT >100 ng haemoglobin/ml for premalignant lesions was 33%.

CONCLUSION:

These results provide preliminary evidence of the willingness of individuals to complete FIT-based CRC screening program in Mexico. However, further evaluation of health systems resources will be needed prior to large-scale implementation of CRC screening programs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Detecção Precoce de Câncer / Sangue Oculto Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Mexico Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Detecção Precoce de Câncer / Sangue Oculto Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Mexico Idioma: En Ano de publicação: 2020 Tipo de documento: Article